Deals this week: AbbVie, Evolva, Trek Therapeutics

AbbVie has entered a clinical trial agreement with Bristol-Myers Squibb Company to evaluate the safety and efficacy of the former ’s Rova-T, as well as in combination with the latter’s Opdivo, along with Opdivo + Yervoy regimen as a treatment for rela…
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news